GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (STU:2DR) » Definitions » Total Liabilities

Inspire Medical Systems (STU:2DR) Total Liabilities : €89.1 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inspire Medical Systems Total Liabilities?

Inspire Medical Systems's Total Liabilities for the quarter that ended in Mar. 2024 was €89.1 Mil.

Inspire Medical Systems's quarterly Total Liabilities increased from Sep. 2023 (€89.31 Mil) to Dec. 2023 (€95.64 Mil) but then declined from Dec. 2023 (€95.64 Mil) to Mar. 2024 (€89.07 Mil).

Inspire Medical Systems's annual Total Liabilities increased from Dec. 2021 (€58.44 Mil) to Dec. 2022 (€65.01 Mil) and increased from Dec. 2022 (€65.01 Mil) to Dec. 2023 (€95.64 Mil).


Inspire Medical Systems Total Liabilities Historical Data

The historical data trend for Inspire Medical Systems's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems Total Liabilities Chart

Inspire Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 37.28 42.29 58.44 65.01 95.64

Inspire Medical Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.76 82.04 89.31 95.64 89.07

Inspire Medical Systems Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Inspire Medical Systems's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=71.622+(22.784+1.234
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=95.6

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=620.636-524.995
=95.6

Inspire Medical Systems's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=66.398+(22.54+0.135
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=89.1

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=630.975-541.902
=89.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspire Medical Systems Total Liabilities Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspire Medical Systems (STU:2DR) Business Description

Traded in Other Exchanges
Address
5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Inspire Medical Systems (STU:2DR) Headlines

No Headlines